Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression
The DOI matches its Crossref record.
Abstract
OBJECTIVE: We previously reported that morning bright light therapy is efficacious in adults with nonseasonal major depressive disorder (MDD), both on its own and in combination with fluoxetine. Given that appetitive symptoms predict response to bright light therapy in seasonal depression, we examined, in this secondary analysis, whether the same held true in these nonseasonal MDD patients. METHODS: Data were collected from October 7, 2009, to March 11, 2014. One hundred twenty-two patients who met DSM-IV-TR criteria for MDD without a seasonal pattern were randomly assigned to light monotherapy, fluoxetine, combination light and fluoxetine, or double-placebo (inactivated negative ion generator plus placebo pill). Multiple regression assessed the percentage change in Montgomery-Asberg Depression Rating Scale (MADRS) scores based on treatment condition, appetitive symptom score at baseline (sum of 4 items on the Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders version), and the condition-by-appetitive score interaction. Sex was considered as a possible moderator of these effects. RESULTS: The overall regression model predicting treatment response was highly significant (P < .001), and the treatment condition-by-appetitive score interaction was a strong predictor of MADRS change scores (t = 2.65, P = .009). For individuals in the placebo group, more appetitive symptoms at baseline predicted less decrease in MADRS scores at 8 weeks (r = -0.37; large effect size). In contrast, for individuals in the active treatment groups, more appetitive symptoms at baseline predicted more of a decrease in depression scores at 8 weeks (fluoxetine group r = +0.23, medium effect size; light therapy group r = +0.11, small effect size; combination group r = +0.32, medium to large effect size). No moderation effect of sex was found. CONCLUSIONS: More severe appetitive symptoms at baseline predicted treatment response differentially across the 4 treatment groups. Contrary to prior findings in seasonal depression, this association was not robust for MDD patients receiving light therapy alone, although it was stronger in patients receiving fluoxetine with or without light. As the group sample sizes were modest, the current findings should be considered as preliminary only. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00958204.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Atypical depressive symptoms have been noted to potentially predict response to light therapy in studies of SAD 32,33 and MDD. 34”
From Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2020) · cites this paper as [34]
Citations
Cites
Still being checked.
Cited by
Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719892471 · Cited by 70
Self-citationBrouwer, A., van Raalte, D. H., Nguyen, H.-T., Rutters, F., van de Ven, P. M., Elders, P. J. M., Moll, A. C., Van Someren, E. J. W., Snoek, F. J., Beekman, A. T. F., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1732 · Cited by 42
“with a stronger appetite and a higher BMI, factors that are associated with insulin resistance (24,25).”
BackgroundInsulin resistance as a marker for the immune-metabolic subtype of depression
Brouwer, A., van Raalte, D. H., Lamers, F., Rutters, F., Elders, P. J. M., Someren, E. J. W. V., Snoek, F. J., Beekman, A. T. F., & Bremmer, M. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.151 · Cited by 37
Adán, A., Navarro, J. F., & on behalf of ADDISCHRONO Group (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071846 · Cited by 7
Vreijling, S. R., Neuhaus, L., Brouwer, A., Penninx, B. W. J. H., Beekman, A. T. F., Lamers, F., Jansen, R., & Bremmer, M. A. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111671 · Cited by 5
Metadata
- Authors
- Levitan, R. D., Levitt, A. J., Michalak, E. E., Morehouse, R., Ramasubbu, R., Yatham, L. N., Tam, E. M., & Lam, R. W.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Sunnybrook Health Science Centre (CA)
- University of British Columbia (CA)
- Dalhousie University (CA)
- University of Calgary (CA)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2018-07-24
- Volume
- 79
- Issue
- 4
- ISSN
- 0160-6689 (ISSN-L)
- 1555-2101
- OpenAlex
- W2883460108
- Cited by
- 8
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 2
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (94832_1)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- bright light therapy, fluoxetine, treatment response prediction, seasonal affective disorder, placebo response, sex differences in treatment response
- MeSH terms
- Adult, Appetitive Behavior, Combined Modality Therapy, Depressive Disorder, Major, Major Depressive Disorder, Female, Fluoxetine, Humans, Male, Phototherapy, Psychiatric Status Rating Scales, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression. https://app.cochat.ai/papers/10.4088/jcp.17m11856
- The paper
- Levitan, R. D., Levitt, A. J., Michalak, E. E., Morehouse, R., Ramasubbu, R., Yatham, L. N., Tam, E. M., & Lam, R. W. (2018). Appetitive Symptoms Differentially Predict Treatment Response to Fluoxetine, Light, and Placebo in Nonseasonal Major Depression. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17m11856
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.